by The global primary cell culture market is witnessing significant growth over the past few years owing to increasing demand for cell-based research in omics fields including genomics, proteomics and metabolomics. Primary cell cultures offer advantages over cell lines such as preservation of cell morphology, gene expression profile and phenotype as they are directly isolated from tissues without undergoing extensive passaging. The primary cell cultures find widespread application in disease modelling, toxicity screening and development of regenerative medicine strategies.
The Global primary cell culture market is estimated to be valued at US$ 5.99 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period 2024 To 2031.
Key Takeaways
Key players operating in the global primary cell culture market are Merck KGaA, Thermo Fisher Scientific, Inc., Danaher, Lonza, PromoCell GmbH, Corning Incorporated, FUJIFILM Irvine Scientific, Inc., Mattek, Axol Bioscience Ltd., ATCC, QIAGEN and HiMedia Laboratories. These key players are focusing on new product launches, acquisitions and partnerships to expand their market presence.
The increasing adoption of 3D cell cultures and organ-on-chip models present significant opportunities in the market. Cell-based assays are also gaining prominence in drug discovery as they better mimic in vivo conditions.
The primary cell culture market is witnessing strong growth in Asia pacific and Europe owing to increasing R&D investments in regenerative medicine and biopharmaceuticals. North America dominates the global market due to presence of major players and advancement in cell-based research.
Market Drivers
One of the major drivers for Global Primary Cell Culture Market growth personalized medicine approaches. The primary cell cultures are useful for developing patient-specific disease models for developing targeted therapies. Further, stringent regulations regarding animal testing have increased the demand for alternative in vitro cell-based assays. The primary cell cultures allow evaluation of drug toxicity and efficacy in more predictive and cost-effective manner. This is further fueling the growth of primary cell culture market.
PEST Analysis
Political: The global primary cell culture market is regulated by various regulatory bodies like FDA and EMA. Any new product development has to get necessary approvals which impacts the market.
Economic: The increasing healthcare expenditure worldwide on disease diagnosis and treatment is fueling the growth of this market. The rising per capita healthcare spending in developing nations provides ample opportunities.
Social: Rising geriatric population prone to chronic diseases and growing awareness about disease diagnosis and treatment are positively influencing the demand. However, high costs associated can limit the market growth to some extent.
Technological: Automated cell culture systems for continuous monitoring and innovative 3D cell culture techniques are gaining traction. The advancements in stem cell therapy and regenerative medicine will further fuel technological developments in primary cell culture.
Because of its well-established Global Primary Cell Culture Market Regional Analysis high healthcare spending, and concentration of significant players, North America accounts for the majority of the market’s value. Its highest proportion is mostly due to the growing number of pharmaceutical businesses and CROs as well as increased biomedical research activities.
Asia Pacific is anticipated to be the fastest growing regional market during the forecast period. Rising awareness, improving healthcare infrastructure along with growing medical tourism are some factors driving the Asia Pacific primary cell culture market. In addition, countries like China and India are witnessing increased government funding for life science research which will positively impact the regional market.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
About Author - Ravina Pandya
Ravina Pandya,a content writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemicals and materials, etc. With an MBA in E-commerce, she has expertise in SEO-optimized content that resonates with industry professionals. LinkedIn Profile
